Đang chuẩn bị liên kết để tải về tài liệu:
Prognostic value of protein inhibitor of activated STAT3 in breast cancer patients receiving hormone therapy

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Deregulated signal transducer and activator of transcription 3 (STAT3) signaling has been well documented in certain cancers. Alterations in specific negative regulators, such as protein inhibitor of activated STAT3 (PIAS3), may contribute to cancer development. |

TÀI LIỆU LIÊN QUAN

The prognostic value of cytokeratin and sal-like protein 4 expression in hepatocellular carcinoma and intra-hepatic cholangiocarcinoma in Taiwan

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer

Prognostic value of preoperative C-reactive protein to albumin ratio in patients with thymic epithelial tumors: A retrospective study

Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: Evidence from a systematic meta-analysis

53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma

The prognostic value of estrogen receptor beta and proline glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer

Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma

Evaluating the prognostic value of ERCC1 and thymidylate synthase expression and the epidermal growth factor receptor mutation status in adenocarcinoma non-small-cell lung cancer

Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma